Skip to main content

Peer Review reports

From: The signature of SARS-CoV-2-related genes predicts the immune therapeutic response and prognosis in breast cancer

Original Submission
30 Jan 2024 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
10 Mar 2024 Reviewed Reviewer Report
23 May 2024 Reviewed Reviewer Report - Sanqi An
28 Aug 2024 Author responded Author comments - Xiaojun Xie
Resubmission - Version 3
28 Aug 2024 Submitted Manuscript version 3
30 Aug 2024 Author responded Author comments - Xiaojun Xie
Resubmission - Version 4
30 Aug 2024 Submitted Manuscript version 4
17 Sep 2024 Reviewed Reviewer Report - Sainitin Donakonda
12 Oct 2024 Author responded Author comments - Xiaojun Xie
Resubmission - Version 5
12 Oct 2024 Submitted Manuscript version 5
Publishing
15 Oct 2024 Editorially accepted
31 Oct 2024 Article published 10.1186/s12920-024-02032-0

You can find further information about peer review here.

Back to article page